Peptilogics Funding: $120M Raised, Series B (2025)
Peptilogics is a Biotech company based in Pittsburgh, PA. It has raised $120M in total funding. Latest round: Series B.
Peptilogics funding overview
Peptilogics is a Biotech company based in Pittsburgh, PA. Peptilogics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2025. The round record for Peptilogics runs through 2025; nothing later has been disclosed. Investors on record include Presight Capital, Thiel Bio, Founders Fund, AMR Action Fund, Narya Capital, Beyond Ventures. 6 distinct backers are named across the disclosed rounds.
Peptilogics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Peptilogics?
Presight Capital, Thiel Bio, Founders Fund, AMR Action Fund, Narya Capital, Beyond Ventures are named among the investors backing Peptilogics.
What was the latest Peptilogics funding round?
The most recent disclosed round is a Series B, announced in October 2025.
Where is Peptilogics based?
Peptilogics is based in Pittsburgh, PA.
What sector does Peptilogics operate in?
Peptilogics is tracked under Biotech from Pittsburgh, PA, with $120M in disclosed funding.
When did Peptilogics last raise?
The last disclosed Peptilogics round closed in October 2025 at Series B.
Peptilogics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Pittsburgh below to benchmark round size and investor mix.
